NF-κB activation by CD26 antigen is independent of dipeptidyl peptidase IV activity

Protoplasma

Volumn 197, Issue 1-2, 1997, Pages 26-33

  Blazquez M V ^a   Ortiz, C ^a   Aranda, E ^a   Collantes, E ^a   Israel A ^b   Munoz E ^a  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b INSTITUT PASTEUR   (France)

Author keywords

CD26 antigen; Dipeptidyl peptidase IV; NF B transcription factor; Tumor cells

Indexed keywords

EID: 0030893754     PISSN: 0033183X     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf01279881     Document Type: Article

References (49)

1. Baeuerle PA, Henkel T (1994) Function and activation of NF-Kappa-B in the immune system. Annu Rev Immunol 12: 141-179
2. Baur A, Garber S, Peterlin BM (1994) Effect of CD45 on NF-KB. J Immunol 152: 976-982
3. Bauvois B (1988) A collagen-binding glycoprotein on the surface of mouse fibroblasts is identified as dipeptidyl peptidase IV. Biochem J 252: 723-731
4. Bose HR Jr (1992) The Rel family: models for transcriptional regulation and oncogenic transformation. Biochim Biophys Acta 1114: 1-17
5. Buc HA, Moncion A, Hamet M, Houllier AM, Thuilier L, Perignon JL (1990) Influence of adenosine deaminase inhibition on the phosphoinositide turnover in the initial stages of human T cell activation. Eur J Immunol 20: 611-616
6. Buhling F, Junker U, Reinhold D, Neubert K, Jager L, Ansorge S (1995) Functional role of CD26 on human B-lymphocytes. Immunol Lett 45: 47-51
7. Chen JZ, Parent L, Maniatis T (1996) Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity. Cell 84: 853-862
8. Dang NH, Torimoto Y, Deusch K, Schlossman SF, Morimoto C (1990a) Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways. J Immunol 144: 4092-4100
9. _ _ Sugita K, Daley JF, Schow P, Prado C, Schlossman SF, Morimoto C (1990b) Cell surface modulation of CD26 by ami-1F7 monoclonal antibody: analysis of surface expression and human T cell activation. J Immunol 145: 3963-3971
10. Darmoul D, Lacasa M, Baricault L, Marguet D, Sapin C, Trotot P, Barbat A, Trugnan G (1992) Dipeptidyl peptidase IV (CD26) gene expression in enterocyte-like colon cancer cell lines HT-29 and Caco-2. J Biol Chem 267: 4824-4833
11. Dirjens WNM, ten Kate J, van der Linden EP, Wijnen JT, Khan PM, Bosman FT (1989) Distribution of adenosine deaminase complexing protein (ADCP) in human tissues. J Histochem Cytochem 37: 1869-1876
12. Finco TS, Baldwin AS Jr (1995) Mechanistic aspects of NF-κB regulation: the emerging role of phosphorylation and proteolysis. Immunity 3: 263-272
13. Fleischer B (1987) A novel pathway of human cell activation via a 103 KD T cell activation antigen. J Immunol 13: 1346-1350
14. _ (1994) CD26: a surface protease involved in T-cell activation. Immunol Today 15: 180-184
15. Sturm E, de Vries JE, Spits H (1988) Triggering of cytotoxic T lymphocytes and NK cells via the Tp103 pathway is dependent on the expression of the T cell receptor/CD3 complex. J Immunol 141: 1103-1107
16. Hafler DA, Chofflon M, Benjamin D, Dang DH, Breitmeyer J (1989) T cell activation and CD3 phosphorylation correlates with Ta1 (CDw26) expression. J Immunol 142: 2590-2596
17. Hegen M, Mittrucker HW, Hugh R, Demuth HU, Neubert K, Barth A, Fleischer B (1993) Enzymatic activity of CD26 (dipeptidyl-peptidase IV) is not required for its signaling function in T cells. Immunobiology 189: 483-493
18. Henkel T, Machleidt T, Alkalay I, Kronke M, Ben-Heriah Y, Baeuerle PA (1993) Rapid proteolysis of I-kappa-B-alpha is necessary for activation of transcription factor NF-kappa-B. Nature 365: 182-185
19. Israel A (1995) A role for phosphorylation and degradation in the controls of NF-kappa-B activity. Trends Genet 11: 203-205
20. Kameoka J, Tanaka T, Nojima Y, Schlossman SF, Morimoto C (1993) Direct association of adenosine deaminase with a T cell activation antigen. CD26. Science 261: 466-469
21. Kieran M, Blank V, Logeat F, Vanderkerckhove J, Lottspeich F, LeBail O, Urban MB, Kourilsky P, Baeuerle PA, Israël A (1990) The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product. Cell 62: 1007-1018
22. Kitajima I, Shinohara TJ, Bilakovics J, Brown DA, Xu X, Nerenberg M (1992) Ablation of transplanted HTLV-I Tax transformed tumors in mice by antisense inhibition of NF-κB. Science 258: 1792-1795
23. Lau KHW, Farley JR, Baylink DJ (1989) Phosphotyrosine protein phosphatases. Biochem J 257: 23-31
24. McCaughan GW, Wickson JE, Creswick PF, Gorrell MD (1990) Identification of the bile canalicular cell surface molecule GP110 as the ectopeptidase dipeptidyl peptidase IV: an analysis by tissue distribution, purification and N-terminal amino acid sequence. Hepatology 11: 534-539
25. Madueño JA, Muñoz E, Blazquez V, Gonzalez R, Aparicio P, Peña J (1993) The CD26 antigen is coupled to protein tyrosine phosphorylation and implicated in CD16-mediated lysis in natural killer cells. Scand J Immunol 37: 425-429
26. Martin M, Huguet J, Centelle JJ, Franco R (1995) Expression of ecto-adenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex. Possible role of adenosine deaminase as costimulatory molecule. J Immunol 155: 4630-4643
27. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J 12: 2005-2015
28. Morimoto C, Torimoto Y, Levinson G, Rudd CE, Schrieher M, Dang NH, Letvin NL, Schlossman SF (1989) 1F7, a novel cell surface molecule, involved in helper function of CD4 cells. J Immunol 143: 3430-3439
29. Munoz E, Blàzquez MV, Madueño JA, Rubio G, Peña J (1992) CD26 induces T-cell proliferation by tyrosine protein phosphorylation. Immunology 77: 43-50
30. Nagatsu T, Hino M, Fuyamda H, Hayakawa T, Sakakibara S, Nakagawa Y, Takemoto T (1976) New chromogenic substrates for X-prolyl dipeptide-aminopeptidase. Anal Biochem 74: 466-176
31. Narayanan R, Klement JF, Rubens SM, Higgins KA, Rosen CA (1993) Identification of a naturally occurring transforming variant of the p65 subunit of NF-Kappa-B. Science 256: 367-370
32. Neri A, Chang CC, Lombardi L, Dalina M, Corradini P, Maiolo AT, Chaganti RSK, Dalla-Favera R (1991) B cell lymphoma-associaled chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-κB p50. Cell 67: 1075-1087
33. Pahl HL, Baeuerle PA (1996) Control of gene expression by proteolysis. Curr Opin Cell Biol 8: 340-347
34. Piazza G, Callanan HM, Mowery J, Hixson DC (1989) Evidence for a role of dipeptidyl peptidase IV in fibronectin-mediated interaction of hepatocytes with extracellular matrix. J Biochem 262: 327-334
35. Reinhold D, Bank U, Buhling F, Kahne T, Kunt d, Faust J, Neubert K, Ansorge S (1994) Inhibitors of dipeptidyl peptidase IV (DP-IV, CD26) specifically suppress proliferation and modulate cytokine production of strongly CD26 expressing U937 cells. Immunobiology 192: 121-136
36. Rice NR, Mackichan ML, Israel A (1992) The precursor of NF-kappaB p50 has IkappaB-like functions. Cell 71: 243-253
37. Riemann D, Kehlen A, Langner J (1995) Stimulation of the expression and the enzyme activity of aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 on human renal cell carcinoma cells and renal tubular epithelial cells by T-cell derived cytokines, such as IL-4 and IL-13. Clin Exp Immunol 100: 277-283
38. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
39. Schreck R, Rieher P, Baeuerle PA (1991) Reactive oxygen intermediates as apparently widely used messenger in the activation of the NF-κB transcription factor and HIV-1. EMBO J 10: 2247-2258
40. Sen R, Baltimore D (1986) Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46: 705-714
41. Steeg C, Hartwig U, Fleischer B (1995) Unchanged signaling capacity of mutant CD26/dipeptidylpeptidase IV molecules devoid of enzymatic activity. Cell Immunol 164: 311-315
42. Tanaka T, Camerini D, Seed B, Torimoto Y, Dang NH, Kameoka J, Dahlberg HN, Schlossman ST, Morimoto C (1992) Cloning and functional expression of the T cell activation antigen CD26. J Immunol 149: 481-486
43. _ Kameoka J, Yaron A, Schlossman SF, Morimoto C (1993) The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity. Proc Natl Acad Sci USA 90: 4586-4590
44. Umeki K, Yamamoto I, Sakamoto F, Noguchi S, Ohtaki S (1995) CD26 (dipeptidyl peptidase IV) as a novel marker for differentiated thyroid carcinoma. Int J Cancer 64: 326-331
45. Thakur S, Lin HC, Tseng WT, Kumar S, Bravo R, Foss F, Gélinas C, Rabson AB (1994) Rearrangement and altered expression of the NF-κB-2 gene in human cutaneous T-lymphoma cells. Oncogene 9: 2335-2344
46. Torimoto Y, Dang NH, Vivier E, Tanaka T, Schlossman SF, Morimoto C (1991) Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes. J Immunol 147: 2514-2517
47. Traenckner EB-M, Wilk S, Baeuerle PA (1994) A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκBα that is still bound to NF-κB. EMBO J 13: 5433-5441
48. Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S (1995) Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev 9: 2723-2735
49. Yoshioka M, Erickson RH, Matsumoto H, Gum E, Kim YS (1991) Expression of dipeptidyl aminopeptidase IV during enterocytic differentiation of human colon cancer (CACO-2) cells. Int J Cancer 47: 916-921